Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.

Dvorak CC, Fisher BT, Sung L, Steinbach WJ, Nieder M, Alexander S, Zaoutis TE.

Pediatr Blood Cancer. 2012 Jul 15;59(1):21-6. doi: 10.1002/pbc.23415. Epub 2011 Nov 18. Review.

2.

Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.

Pechlivanoglou P, Le HH, Daenen S, Snowden JA, Postma MJ.

J Antimicrob Chemother. 2014 Jan;69(1):1-11. doi: 10.1093/jac/dkt329. Epub 2013 Aug 23. Review.

3.

Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.

Winston DJ, Bartoni K, Territo MC, Schiller GJ.

Biol Blood Marrow Transplant. 2011 Apr;17(4):507-15. doi: 10.1016/j.bbmt.2010.04.017. Epub 2010 May 9.

4.

Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.

Maertens J.

Eur J Haematol. 2007 Apr;78(4):275-82. Epub 2007 Jan 23. Review.

PMID:
17241370
5.

[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].

Salavert M, Jarque I.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:43-9. doi: 10.1016/S0213-005X(11)70009-X. Review. Spanish.

PMID:
21420577
6.

The role of primary antifungal prophylaxis in patients with haematological malignancies.

Pagano L, Caira M.

Clin Microbiol Infect. 2014 Jun;20 Suppl 6:19-26. doi: 10.1111/1469-0691.12464. Epub 2014 Feb 3. Review.

7.

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation.

Hiramatsu Y, Maeda Y, Fujii N, Saito T, Nawa Y, Hara M, Yano T, Asakura S, Sunami K, Tabayashi T, Miyata A, Matsuoka K, Shinagawa K, Ikeda K, Matsuo K, Tanimoto M; West-Japan Hematology and Oncology Group.

Int J Hematol. 2008 Dec;88(5):588-95. doi: 10.1007/s12185-008-0196-y. Epub 2008 Nov 29.

PMID:
19039629
8.

The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan.

Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T.

J Pediatr Hematol Oncol. 2008 Dec;30(12):886-90. doi: 10.1097/MPH.0b013e3181864a80.

PMID:
19131772
9.

Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.

Ping B, Zhu Y, Gao Y, Yue C, Wu B.

Ann Hematol. 2013 Jun;92(6):831-9. doi: 10.1007/s00277-013-1693-5. Epub 2013 Feb 28. Review.

PMID:
23455400
10.

Antifungal prophylaxis and treatment in patients with hematological malignancies.

Hwang YY, Liang R.

Expert Rev Anti Infect Ther. 2010 Apr;8(4):397-404. doi: 10.1586/eri.10.16. Review.

PMID:
20377335
11.

Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.

Shen Y, Huang XJ, Wang JX, Jin J, Hu JD, Yu K, Wu DP, Wang SJ, Yu L, Chen XQ, Liu T, Liang YM, Chen FP, Li Y, Shen ZX.

Int J Clin Pharmacol Ther. 2013 Sep;51(9):738-45. doi: 10.5414/CP201880.

PMID:
23924680
12.

Posaconazole: an extended-spectrum triazole antifungal agent.

Schiller DS, Fung HB.

Clin Ther. 2007 Sep;29(9):1862-86. Review.

PMID:
18035188
13.

Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

Clerihew L, Austin N, McGuire W.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003850. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD003850.

PMID:
17943803
14.

Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis.

Kaya Z, Gursel T, Kocak U, Aral YZ, Kalkanci A, Albayrak M.

Pediatr Blood Cancer. 2009 Apr;52(4):470-5. doi: 10.1002/pbc.21868.

PMID:
19058205
15.

Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.

Mandhaniya S, Swaroop C, Thulkar S, Vishnubhatla S, Kabra SK, Xess I, Bakhshi S.

J Pediatr Hematol Oncol. 2011 Dec;33(8):e333-41. doi: 10.1097/MPH.0b013e3182331bc7.

PMID:
22042283
16.

[Prophylaxis of fungal infections in haematological patients: contra].

Schwartz S.

Dtsch Med Wochenschr. 2010 Sep;135(38):1871. doi: 10.1055/s-0030-1263330. Epub 2010 Sep 14. German. No abstract available.

PMID:
20842608
17.

Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.

Vehreschild MJ, von Bergwelt-Baildon M, Tran L, Shimabukuro-Vornhagen A, Wisplinghoff H, Bangard C, Cornely OA, Vehreschild JJ.

Eur J Haematol. 2014 Nov;93(5):400-6. doi: 10.1111/ejh.12368. Epub 2014 May 26.

PMID:
24798021
18.

Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

Mehta PA, Vinks AA, Filipovich A, Bleesing J, Jodele S, Jordan MB, Marsh R, Tarin R, Edwards S, Fearing D, Lawrence J, Davies SM.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1458-62. doi: 10.1016/j.bbmt.2010.05.002. Epub 2010 Jun 20. Erratum in: Biol Blood Marrow Transplant. 2011 Mar;17(3):441.

19.

Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia.

Fisher BT, Kavcic M, Li Y, Seif AE, Bagatell R, Huang YS, Zaoutis T, Torp K, Leckerman KH, Aplenc R.

Clin Infect Dis. 2014 Feb;58(4):502-8. doi: 10.1093/cid/cit781. Epub 2013 Nov 23.

20.

Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies.

Hirata Y, Yokote T, Kobayashi K, Nakayama S, Oka S, Miyoshi T, Akioka T, Hiraoka N, Iwaki K, Takayama A, Nishimura Y, Makino J, Takubo T, Tsuji M, Hanafusa T.

Leuk Lymphoma. 2010 May;51(5):853-9. doi: 10.3109/10428191003682726.

PMID:
20214445
Items per page

Supplemental Content

Write to the Help Desk